The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Candida albicans is an emerging multidrug-resistant fungal pathogen representing an
important source of invasive disease in humans and generating high healthcare costs …

Infectious diseases are important causes of morbidity and mortality in patients with cancer.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and …

The presence of commensal fungal species in the human gut indicates that organisms from
this kingdom have the potential to benefit the host as well. Saccharomyces boulardii, a yeast …

A substantial proportion of patients become colonised with Candida spp during hospital
stay, but only few subsequently develop severe infection. Clinical signs of severe infection …

Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of
morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic …

T cells are required for normal host defense against fungal infection, and individuals with T
cell. deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is …

To determine the incidence of Candida bloodstream infections (BSI) and antifungal drug
resistance, population-based active laboratory surveillance was conducted from October …

Patients with cancer are at increased risk for developing infectious complications during the
course of their disease and treatment. The following sections of the NCCN Clinical Practice …

BACKGROUND. The objective of the current retrospective study was to compare the
epidemiology of candidemia and its risk factors in patients who had hematologic …